Skip to main content

Processa Pharmaceuticals, Inc.

For the period ended Jun 18, 2026. Filed Jun 18, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 18, 2026 · Filed Jun 18, 2026

PCSA$1.93+4.9%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Pay Versus Performance

Pay Versus Performance Table*

In accordance with rules adopted by the Securities and Exchange Commission (“SEC”), we are providing the following disclosure regarding executive “compensation actually paid,” presented in a manner consistent with the rules applicable to smaller reporting companies. The amounts in the table below are calculated in accordance with SEC rules and do not represent amounts actually earned or realized by our named executive officers (“NEOs”).

YearSummary Compensation Table Total for PEO (George Ng) ($)Compensation Actually Paid to PEO (George Ng) ($) (a)Average Summary Compensation Table Total for Non-PEO NEOs ($) (b)Average Compensation Actually Paid to Non-PEO NEOs ($) (c)Value of Initial Fixed $100 Investment Based on the Total Shareholder Return of the Company ($) (d)Net Income (Loss) ($ in thousands) (e)
2025673,303565,067530,986483,384213,564
2024521,033288,393286,239268,03813(11,850)
2023472,849428,849321,702225,343100(11,122)
(a)Compensation actually paid (“CAP”) reflect the adjustments listed in the tables below to the amounts reported in the Summary Compensation Table for our PEO:

George Ng:

Year202320242025
SCT Total Compensation ($)472,849521,033673,303
Less: Stock and Option Award Values Reported in SCT for the Covered Year ($)(312,000)-(199,373)
Plus: Fair Value for Stock and Option Awards Granted in the Covered Year that are Outstanding and Unvested at End of Year ($)268,000-115,047
Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years ($)-(180,930)(3,364)
Fair Value as of Vesting Date for Awards Granted that Vested in Same Year ($)---
Change in Fair Value of Stock and Option Awards from Prior years that Vested in the Covered Year ($)-(51,710)(20,546)
Less: Fair Value of Stock and Option Awards Forfeited during the covered Year ($)---
Less: Aggregate Change in Actuarial Present Value of Accumulated Benefit Under Pension Plans ($)---
Plus: Aggregate Service Cost and Prior Service Cost for Pension Plans ($)---
Compensation Actually Paid ($)428,849288,393565,067
(c)The average figures shown include Russell Skibsted and Sian Bigora:
(d)Compensation actually paid (CAP) to our non-PEO NEOs reflects the respective amounts set forth in column (d) of the table above, adjusted as set forth in the table below. The assumptions used to calculate the fair values did not differ materially from the assumptions used to calculate the fair values as of the grant dates.
Year202320242025
Non-PEO NEOsSee column (c) note aboveSee column (c) note aboveSee column (c) note above
SCT Total Compensation ($)321,702286,239530,986
Less: Stock and Option Award Values Reported in SCT for the Covered Year ($)(136,837)(31,742)(79,495)
Plus: Fair Value for Stock and Option Awards Granted in the Covered Year ($)41,70815,26145,839
Change in Fair Value of Outstanding Unvested Stock and Option Awards from Prior Years ($)(596)(298)(3,287)
Fair Value as of Vesting Date for Awards Granted that Vested in Same Year ($)-759-
Change in Fair Value of Stock and Option Awards from Prior years that Vested in the Covered Year ($)(634)(2,181)(10,360)
Less: Fair Value of Stock and Option Awards Forfeited during the covered Year ($)---
Less: Aggregate Change in Actuarial Present Value of Accumulated Benefit Under Pension Plans ($)---
Plus: Aggregate Service Cost and Prior Service Cost for Pension Plans ($)---
Compensation Actually Paid ($)225,343268,038483,684
(e)Total shareholder return is determined based on the value of an initial fixed investment of $100 in our common stock as of January 1, 2023.
(f)Reflects “Net Income” in the company’s audited financial statement included in our Annual Reports on Form 10-K for each of the years ended December 31, 2023, 2024 and 2025.

Pay Versus Performance Descriptive Disclosure

Below are graphs showing the relationship of “compensation actually paid” to our PEOs and non-PEO NEOs in 2023, 2024, and 2025 to (1) our TSR and (2) our net income.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.